We will continue to strive for global new drug development. NEWS HOME News Search No Subject Date View 4 Dong-A ST Unveils Cutting-Edge Immuno-Oncology Drug Candidate 'DA-4511' at AACR-NCI-EORTC 2023 2023-12-19 976 3 HK inno.N set to develop 5th-generation lung cancer drug 2023-12-19 1895 2 Dong-A ST eyes Europe market with Stelara biosimilar 2023-12-18 988 1 Dong-A ST Announces Promising Results of Immune Oncology Candidate DA-4505 at AACR 2023 2023-09-22 1417 1 2 3
